- Mfr:
- Boehringer Ingelheim Fremont, Inc.
- Form:
- Liquid
Active: Pembrolizumab 25 mg/25mg
83012-001010 NDC products found in the FDA database
Active: Pembrolizumab 25 mg/25mg
83012-0010Active: Pembrolizumab 25 mg/mL
12714-0090Active: Pembrolizumab 165 mg/mL
12714-0091Active: Berahyaluronidase Alfa 2000 U/mL · Pembrolizumab 165 mg/mL
Active: Berahyaluronidase Alfa 2000 U/mL · Pembrolizumab 165 mg/mL
Pembrolizumab And Berahyaluronidase Alfa-Pmph
Active: Berahyaluronidase Alfa 2000 U/mL · Pembrolizumab 165 mg/mL
Pembrolizumab And Berahyaluronidase Alfa-Pmph
Active: Berahyaluronidase Alfa 2000 U/mL · Pembrolizumab 165 mg/mL
Active: Pembrolizumab 25 mg/mL
69497-0001Active: Pembrolizumab 25 mg/mL
75895-0136Pembrolizumab
Active: Pembrolizumab 25 mg/mL
00006-3026